In plain language
This review of published data on interventional cardiologists reports up to 1000-fold variation in operator dose per procedure and little decline over time, and notes that several patient, physician and shielding factors operators can adjust at little cost may substantially lower dose.
At a glance
- Type of study
- Narrative review
- Who was studied
- Interventional cardiologists
- Topics
- Dosimetry and monitoringDose reduction techniquesRoom shielding and protective devicesCancer risk
- Summary based on
- the abstract
What it found
Operator radiation dose per cardiac procedure varies widely across reports.
Key figures: up to 1000-fold
Operator doses have shown little or no reduction over time despite improvements in equipment and technology.
Patient, physician and shielding factors all influence operator dose to different degrees.
Operators can change some dose factors immediately at minimal or no cost, substantially reducing dose and potential cancer risk.
Limits to keep in mind
Narrative review summarized from an abstract only; no pooled numbers, methods for study selection, or quantified effects of individual protective factors are given.
Related research summaries
- Radiation exposure in interventional cardiology: a narrative review of health effects and novel approaches to ensure radiation safety (2025, Narrative review)
- Radiation Safety in Chronic Total Occlusion Percutaneous Coronary Intervention (2025, Narrative review)
- Addressing the Occupational Risk of Radiation Exposure in the Evolving Field of Interventional Echocardiography (2024, Narrative review)
- Radiation Exposure, Training, and Safety in Cardiology (2024, Narrative review)
- Radiation protection practices in diagnostic and interventional cardiology: Position paper from Portuguese Association of Interventional Cardiology (2025, Guideline or consensus statement)
How this summary was made
ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.
Prepared November 3, 2026.